Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

LErafAON improves tumor chemotherapy effectiveness in preclinical studies

April 23, 2002

Cell Therapeutics presents data on metabolism of CT-2103

April 23, 2002

Takeda presents new orally active antitumor agent for HER2-positive cancers

April 22, 2002

Small-molecule GnRH antagonist with good oral bioavailability presented at AACR meeting

April 22, 2002

Small-molecule inhibitors of FAH designed at Bayer as potential agents for NSCLC

April 22, 2002

CKD-732 examined for pharmacokinetic and metabolic profile in vitro and in vivo

April 22, 2002

All four components of PHY-906 necessary for biological activity as chemotherapy adjuvant

April 22, 2002

Lead Androgenics compound blocks androgen receptor activation at an early step

April 22, 2002

Novogen's phenoxodiol stabilizes tumor growth with minimal toxicity

April 19, 2002

Snapshots of new roles for testosterone in neurological and cardiac disorders

April 19, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...